NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$14.07M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$7.06M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.93M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$5.71M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$14.07M | (m) | (m) | (m) | (m) | -$4.77M* | (m) | $2.65M | (m) | (m) |
| 2026-03-31 | Reported | (m) | -$7.06M | (m) | (m) | (m) | (m) | -$6.99M | (m) | $1.29M | (m) | (m) |
| 2025-09-30 | Reported | (m) | -$6.93M | (m) | (m) | (m) | (m) | -$5.81M* | (m) | $715.04K | (m) | (m) |
| 2025-06-30 | Reported | (m) | -$5.71M | (m) | (m) | (m) | (m) | -$5.31M* | (m) | $677.33K | (m) | (m) |
| 2025-03-31 | Reported | (m) | -$31.90M | (m) | (m) | (m) | (m) | -$5.65M | (m) | $998.22K | $134.91K | (m) |
| 2024-09-30 | Reported | (m) | -$2.20M | (m) | (m) | (m) | (m) | -$3.09M* | (m) | $956.73K | (m) | (m) |
| 2024-06-30 | Reported | (m) | -$1.28M | (m) | (m) | (m) | (m) | -$318.20K* | (m) | $394.48K | (m) | (m) |
| 2024-03-31 | Reported | (m) | -$1.55M | (m) | (m) | (m) | (m) | $145.75K | (m) | $614.52K | $137.30K | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$58.24M | (m) | (m) | (m) | (m) | -$20.36M | (m) | $3.64M | (m) | (m) |
| 2024-12-31 | Reported | (m) | -$7.14M | (m) | (m) | (m) | (m) | -$4.21M | (m) | $3.05M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |